THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
164,032,510
Share change
+10,768,853
Total reported value
$1,180,505,857
Put/Call ratio
92%
Price per share
$7.20
Number of holders
133
Value change
+$86,656,418
Number of buys
64
Number of sells
61

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2017

As of 31 Mar 2017, THERAPEUTICSMD INC - COM (TXMD) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 164,032,510 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, JPMORGAN CHASE & CO, BlackRock Inc., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, STATE STREET CORP, GREAT POINT PARTNERS LLC, and GILDER GAGNON HOWE & CO LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.